Multilevel mechanism of immune checkpoint inhibitor action in solid tumors: History, present issues and future development (Review)
- Authors:
- Natalya Lisovska
-
Affiliations: Chemotherapy Department, Center of Oncology, ‘Cyber Clinic of Spizhenko’, Kapitanovka, Kyiv 08112, Ukraine - Published online on: April 29, 2022 https://doi.org/10.3892/ol.2022.13310
- Article Number: 190
-
Copyright: © Lisovska . This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
|
Rosenberg SA: Raising the bar: The curative potential of human cancer immunotherapy. Sci Transl Med. 4:127ps82012. View Article : Google Scholar : PubMed/NCBI | |
|
Kitamura T, Qian BZ and Pollard JW: Immune cell promotion of metastasis. Nat Rev Immunol. 15:73–86. 2015. View Article : Google Scholar | |
|
Ribas A and Wolchok JD: Cancer immunotherapy using checkpoint blockade. Science. 359:1350–135. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Sun L, Zhang L, Yu J, Zhang Y, Pang X, Ma C, Shen M, Ruan S, Wasan HS and Qiu S: Clinical efficacy and safety of anti-PD-1/PD-L1 inhibitors for the treatment of advanced or metastatic cancer: A systematic review and meta-analysis. Sci Rep. 10:20832020. View Article : Google Scholar : PubMed/NCBI | |
|
Curiel TJ: Regulatory T cells and treatment of cancer. Curr Opin Immunol. 20:241–246. 2008. View Article : Google Scholar | |
|
Shergold AL, Millar R and Nibbs RJB: Understanding and overcoming the resistance of cancer to PD-1/PD-L1 blockade. Pharmacol Res. 145:1042582019. View Article : Google Scholar : PubMed/NCBI | |
|
Davis AA and Patel VG: The role of PD-L1 expression as a predictive biomarker: An analysis of all US food and drug administration (FDA) approvals of immune checkpoint inhibitors. J Immunother Cancer. 7:2782019. View Article : Google Scholar : PubMed/NCBI | |
|
Postow MA, Callahan MK and Wolchok JD: Immune checkpoint blockade in cancer therapy. J Clin Oncol. 33:1974–1982. 2015. View Article : Google Scholar | |
|
Wu M, Zhang Y, Zhang Y, Liu Y, Wu M and Ye Z: Imaging-based Biomarkers for predicting and evaluating cancer immunotherapy response. Radiol Imaging Cancer. 1:e1900312019. View Article : Google Scholar : PubMed/NCBI | |
|
Lei X, Lei Y, Li JK, Du WX, Li RG, Yang J, Li J, Li F and Tan HB: Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy. Cancer Lett. 470:126–133. 2020. View Article : Google Scholar | |
|
Ehrlich P: Über den jetzigen stand der karzinomforschung. Ned Tijdshr Geneeskd. 5:273–290. 1909. | |
|
Burnet M: Cancer: A biological approach. III. Viruses associated with neoplastic conditions. IV. Practical applications. Br Med J. 1:841–847. 1957. View Article : Google Scholar : PubMed/NCBI | |
|
Dunn GP, Old LJ and Schreiber RD: The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 21:137–148. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Thomas L: On immunosurveillance in human cancer. Yale J Biol Med. 55:329–333. 1982.PubMed/NCBI | |
|
Kim R, Emi M and Tanabe K: Cancer immunoediting from immune surveillance to immune escape. Immunology. 121:1–14. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Hodgkin PD: Modifying clonal selection theory with a probabilistic cell. Immunol Rev. 285:249–262. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Ribatti D: The concept of immune surveillance against tumors. The first theories. Oncotarget. 8:7175–7180. 2017. View Article : Google Scholar | |
|
Dunn GP, Bruce AT, Ikeda H, Old LJ and Schreiber RD: Cancer immunoediting: From immunosurveillance to tumor escape. Nat Immunol. 3:991–998. 2002. View Article : Google Scholar | |
|
Schreiber RD, Old LJ and Smyth MJ: Cancer immunoediting: Integrating immunity's roles in cancer suppression and promotion. Science. 331:1565–1570. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Hu W and Pasare C: Location, location, location: Tissue-specific regulation of immune responses. J Leukoc Biol. 94:409–421. 2013. View Article : Google Scholar | |
|
Bersanelli M and Buti S: From targeting the tumor to targeting the immune system: Transversal challenges in oncology with the inhibition of the PD-1/PD-L1 axis. World J Clin Oncol. 8:37–53. 2017. View Article : Google Scholar | |
|
Liang J, Balachandra S, Ngo S and O'Brien LE: Feedback regulation of steady-state epithelial turnover and organ size. Nature. 548:588–591. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Lui PP, Cho I and Ali N: Tissue regulatory T cells. Immunology. 161:4–17. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Klose CSN and Artis D: Innate lymphoid cells control signaling circuits to regulate tissue-specific immunity. Cell Res. 30:475–491. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Schutte B and Ramaekers FC: Molecular switches that govern the balance between proliferation and apoptosis. Prog Cell Cycle Res. 4:207–217. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Shechter R, London A and Schwartz M: Orchestrated leukocyte recruitment to immune-privileged sites: Absolute barriers versus educational gates. Nat Rev Immunol. 13:206–218. 2013. View Article : Google Scholar | |
|
Burzyn D, Benoist C and Mathis D: Regulatory T cells in nonlymphoid tissues. Nat Immunol. 14:1007–1013. 2013. View Article : Google Scholar | |
|
Dong J, Chen Y, Xu X, Jin R, Teng F, Yan F, Tang H, Li P, Sun X, Li Y, et al: Homeostatic properties and phenotypic maturation of murine CD4+ pre-thymic emigrants in the thymus. PLoS One. 8:e563782013. View Article : Google Scholar : PubMed/NCBI | |
|
Dobrzanski MJ: Expanding roles for CD4 T cells and their subpopulations in tumor immunity and therapy. Front Oncol. 3:632013. View Article : Google Scholar | |
|
Lee HM, Bautista JL, Scott-Browne J, Mohan JF and Hsieh CS: A broad range of self-reactivity drives thymic regulatory T cell selection to limit responses to self. Immunity. 37:475–486. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Geenen V: The thymus and the science of self. Semin Immunopathol. 43:5–14. 2021. View Article : Google Scholar | |
|
Hsieh CS, Lee HM and Lio CW: Selection of regulatory T cells in the thymus. Nat Rev Immunol. 12:157–167. 2012. View Article : Google Scholar | |
|
Muller WA: How endothelial cells regulate transmigration of leukocytes in the inflammatory response. Am J Pathol. 184:886–896. 2014. View Article : Google Scholar | |
|
Singh NK, Riley TP, Baker SCB, Borrman T, Weng Z and Baker BM: Emerging concepts in TCR specificity: Rationalizing and (Maybe) predicting outcomes. J Immunol. 199:2203–2213. 2017. View Article : Google Scholar | |
|
Sethna Z, Elhanati Y, Dudgeon CR, Callan CG Jr, Levine AJ, Mora T and Walczak AM: Insights into immune system development and function from mouse T-cell repertoires. Proc Natl Acad Sci USA. 114:2253–2258. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Anders HJ, Romagnani P and Mantovani A: Pathomechanisms: Homeostatic chemokines in health, tissue regeneration, and progressive diseases. Trends Mol Med. 20:154–165. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Corrado C, Raimondo S, Chiesi A, Ciccia F, De Leo G and Alessandro R: Exosomes as intercellular signaling organelles involved in health and disease: Basic science and clinical applications. Int J Mol Sci. 14:5338–5366. 2013. View Article : Google Scholar | |
|
Senovilla L, Galluzzi L, Zitvogel L and Kroemer G: Immunosurveillance as a regulator of tissue homeostasis. Trends Immunol. 34:471–481. 2013. View Article : Google Scholar | |
|
Munoz MA, Biro M and Weninger W: T cell migration in intact lymph nodes in vivo. Curr Opin Cell Biol. 30:17–24. 2014. View Article : Google Scholar | |
|
Mai J, Virtue A, Shen J, Wang H and Yang XF: An evolving new paradigm: Endothelial cells-conditional innate immune cells. J Hematol Oncol. 6:612013. View Article : Google Scholar | |
|
Ruddle NH: Lymphatic vessels and tertiary lymphoid organs. J Clin Invest. 124:953–959. 2014. View Article : Google Scholar | |
|
Schaerli P, Ebert L, Willimann K, Blaser A, Roos RS, Loetscher P and Moser B: A skin-selective homing mechanism for human immune surveillance T cells. J Exp Med. 199:1265–1275. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Smigiel KS, Srivastava S, Stolley JM and Campbell DJ: Regulatory T-cell homeostasis: Steady-state maintenance and modulation during inflammation. Immunol Rev. 259:40–59. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Thiault N, Darrigues J, Adoue V, Gros M, Binet B, Perals C, Leobon B, Fazilleau N, Joffre OP, Robey EA, et al: Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors. Nat Immunol. 16:628–634. 2015. View Article : Google Scholar | |
|
Fu H, Ward EJ and Marelli-Berg FM: Mechanisms of T cell organotropism. Cell Mol Life Sci. 73:3009–3033. 2016. View Article : Google Scholar | |
|
Rothstein DM and Camirand G: New insights into the mechanisms of Treg function. Curr Opin Organ Transplan. 20:376–384. 2015. View Article : Google Scholar | |
|
Mittelbrunn M and Sánchez-Madrid F: Intercellular communication: Diverse structures for exchange of genetic information. Nat Rev Mol Cell Biol. 13:328–335. 2012. View Article : Google Scholar | |
|
Kouwaki T, Okamoto M, Tsukamoto H, Fukushima Y and Oshiumi H: Extracellular vesicles deliver host and virus RNA and regulate innate immune response. Int J Mol Sci. 18:6662017. View Article : Google Scholar | |
|
Villarroya-Beltri C, Gutiérrez-Vázquez C, Sánchez-Cabo F, Pérez-Hernández D, Vázquez J, Martin-Cofreces N, Martinez-Herrera DJ, Pascual-Montano A, Mittelbrunn M and Sánchez-Madrid F: Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat Commun. 4:29802013. View Article : Google Scholar : PubMed/NCBI | |
|
Feng D, Zhao WL, Ye YY, Bai XC, Liu RQ, Chang LF, Zhou Q and Sui SF: Cellular internalization of exosomes occurs through phagocytosis. Traffic. 11:675–687. 2010. View Article : Google Scholar | |
|
Morelli AE, Larregina AT, Shufesky WJ, Sullivan ML, Stolz DB, Papworth GD, Zahorchak AF, Logar AJ, Wang Z, Watkins SC, et al: Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood. 104:3257–3266. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Colombo M, Raposo G and Théry C: Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 30:255–289. 2014. View Article : Google Scholar | |
|
Mao X and Jin F: The exosome and breast cancer cell plasticity. Onco Targets Ther. 12:9817–9825. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Green DR, Droin N and Pinkoski M: Activation-induced cell death in T cells. Immunol Rev. 193:70–81. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Ventimiglia LN and Alonso MA: Biogenesis and function of T cell-derived exosomes. Front Cell Dev Biol. 4:842016. View Article : Google Scholar | |
|
Chinn IK, Blackburn CC, Manley NR and Sempowski GD: Changes in primary lymphoid organs with aging. Semin Immunol. 24:309–320. 2012. View Article : Google Scholar | |
|
Ucar O, Li K, Dvornikov D, Kreutz C, Timmer J, Matt S, Brenner L, Smedley C, Travis MA, Hofmann TG, et al: A thymic epithelial stem cell pool persists throughout ontogeny and is modulated by TGF-β. Cell Rep. 17:448–457. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Geenen V, Trussart C, Michaux H, Halouani A, Jaïdane H, Collée C, Renard C, Daukandt M, Ledent P and Martens H: The presentation of neuroendocrine self-peptides in the thymus: An essential event for individual life and vertebrate survival. Ann NY Acad Sci. 1455:113–125. 2019. View Article : Google Scholar | |
|
Caton AJ, Kropf E, Simons DM, Aitken M, Weissler KA and Jordan MS: Strength of TCR signal from self-peptide modulates autoreactive thymocyte deletion and Foxp3(+) Treg-cell formation. Eur J Immunol. 44:785–793. 2014. View Article : Google Scholar | |
|
Saran N, Łyszkiewicz M, Pommerencke J, Witzlau K, Vakilzadeh R, Ballmaier M, von Boehmer H and Krueger A: Multiple extrathymic precursors contribute to T-cell development with different kinetics. Blood. 115:1137–1144. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Tang Q, Jiang D, Harfuddin Z, Cheng K, Moh MC and Schwarz H: Regulation of myelopoiesis by CD137L signaling. Int Rev Immunol. 33:454–469. 2014. View Article : Google Scholar | |
|
Medler TR and Coussens LM: Duality of the immune response in cancer: Lessons learned from skin. J Invest Dermatol. 134:E23–E28. 2014. View Article : Google Scholar | |
|
Egeblad M, Nakasone ES and Werb Z: Tumors as organs: Complex tissues that interface with the entire organism. Dev Cell. 18:884–901. 2010. View Article : Google Scholar | |
|
de Visser KE, Eichten A and Coussens LM: Paradoxical roles of the immune system during cancer development. Nat Rev Cancer. 6:24–37. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Re RN and Cook JL: An intracrine view of angiogenesis. Bioessays. 28:943–953. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Kumar P, Bhattacharya P and Prabhakar BS: A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity. J Autoimmun. 95:77–99. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Seyfried TN and Huysentruyt LC: On the origin of cancer metastasis. Crit Rev Oncog. 18:43–73. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Keskinov AA and Shurin MR: Myeloid regulatory cells in tumor spreading and metastasis. Immunobiology. 220:236–242. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Kovács KA, Hegedus B, Kenessey I and Tímár J: Tumor type-specific and skin region-selective metastasis of human cancers: Another example of the ‘seed and soil’ hypothesis. Cancer Metastasis Rev. 32:493–499. 2013. View Article : Google Scholar | |
|
Caixeiro NJ, Kienzle N, Lim SH, Spring KJ, Tognela A, Scott KF, de Souza P and Becker TM: Circulating tumour cells-a bona fide cause of metastatic cancer. Cancer Metastasis Rev. 33:747–756. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Ben-Baruch A: Organ selectivity in metastasis: Regulation by chemokines and their receptors. Clin Exp Metastasis. 25:345–356. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Satelli A, Mitra A, Brownlee Z, Xia X, Bellister S, Overman MJ, Kopetz S, Ellis LM, Meng QH and Li S: Epithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progression. Clin Cancer Res. 21:899–906. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Sceneay J, Smyth MJ and Möller A: The pre-metastatic niche: Finding common ground. Cancer Metastasis Rev. 32:449–464. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Paduch R: The role of lymphangiogenesis and angiogenesis in tumor metastasis. Cell Oncol (Dordr). 39:397–410. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Spinella F, Caprara V, Cianfrocca R, Rosanò L, Di Castro V, Garrafa E, Natali PG and Bagnato A: The interplay between hypoxia, endothelial and melanoma cells regulates vascularization and cell motility through endothelin-1 and vascular endothelial growth factor. Carcinogenesis. 35:840–848. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Horton BL and Gajewski TF: Back from the dead: TIL apoptosis in cancer immune evasion. Br J Cancer. 118:309–311. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Smith HA and Kang Y: The metastasis-promoting roles of tumor-associated immune cells. J Mol Med (Berl). 91:411–429. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Quail DF and Joyce JA: Microenvironmental regulation of tumor progression and metastasis. Nat Med. 19:1423–1437. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Lee JH, Chen Y, Chan JL, Qian YW and Goydos JS: Molecular analysis of melanoma-induced sentinel lymph node immune dysfunction. Cancer Immunol Immunother. 60:685–692. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Lagios MD: Clinical significance of immunohistochemically detectable epithelial cells in sentinel lymph node and bone marrow in breast cancer. J Surg Oncol. 83:1–4. 2003. View Article : Google Scholar | |
|
Nishikawa H and Sakaguchi S: Regulatory T cells in tumor immunity. Int J Cancer. 127:759–767. 2010.PubMed/NCBI | |
|
Sakaguchi S, Yamaguchi T, Nomura T and Ono M: Regulatory T cells and immune tolerance. Cell. 133:775–787. 2008. View Article : Google Scholar | |
|
Brzostek J and Gascoigne NRJ: Thymic origins of T cell receptor alloreactivity. Transplantation. 101:1535–1541. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Ariotti S, Beltman JB, Chodaczek G, Hoekstra ME, Van Beek AE, Gomez-Eerland R, Ritsma L, van Rheenen J, Marée AF, Zal T, et al: Tissue-resident memory CD8+ T cells continuously patrol skin epithelia to quickly recognize local antigen. Proc Natl Acad Sci USA. 109:19739–19744. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Deleeuw RJ, Kost SE, Kakal JA and Nelson BH: The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer: A critical review of the literature. Clin Cancer Res. 18:3022–3029. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Aggarwal S, Sharma SC and N Das S: Dynamics of regulatory T cells (Tregs) in patients with oral squamous cell carcinoma. J Surg Oncol. 116:1103–1113. 2017. View Article : Google Scholar | |
|
Protti MP, De Monte L and Di Lullo G: Tumor antigen-specific CD4+ T cells in cancer immunity: From antigen identification to tumor prognosis and development of therapeutic strategies. Tissue Antigens. 83:237–246. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Mailloux AW and Young MR: Regulatory T-cell trafficking: From thymic development to tumor-induced immune suppression. Crit Rev Immunol. 30:435–447. 2010. View Article : Google Scholar | |
|
Huang X, Chen Z, Zhang N, Zhu C, Lin X, Yu J, Chen Z, Lan P and Wan Y: Increase in CD4+FOXP3+ regulatory T cell number and upregulation of the HGF/c-Met signaling pathway during the liver metastasis of colorectal cancer. Oncol Lett. 20:2113–2118. 2020. View Article : Google Scholar | |
|
Hamidinia M, Ghafourian Boroujerdnia M, Talaiezadeh A, Solgi G, Roshani R, Iranprast S and Khodadadi A: Increased P-35, EBI3 transcripts and other treg markers in peripheral blood mononuclear cells of breast cancer patients with different clinical stages. Adv Pharm Bull. 5:261–267. 2015. View Article : Google Scholar | |
|
Vasco C, Canazza A, Rizzo A, Mossa A, Corsini E, Silvani A, Fariselli L, Salmaggi A and Ciusani E: Circulating T regulatory cells migration and phenotype in glioblastoma patients: An in vitro study. J Neurooncol. 115:353–363. 2013. View Article : Google Scholar | |
|
Zhang X, Kelaria S, Kerstetter J and Wang J: The functional and prognostic implications of regulatory T cells in colorectal carcinoma. J Gastrointest Oncol. 6:307–313. 2015. | |
|
Chen X and Oppenheim JJ: Resolving the identity myth: Key markers of functional CD4+FoxP3+ regulatory T cells. Int Immunopharmacol. 11:1489–1496. 2011. View Article : Google Scholar | |
|
Ladoire S, Arnould L, Apetoh L, Coudert B, Martin F, Chauffert B, Fumoleau P and Ghiringhelli F: Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3+ regulatory T cells. Clin Cancer Res. 14:2413–2420. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Teng MW, Ngiow SF, von Scheidt B, McLaughlin N, Sparwasser T and Smyth MJ: Conditional regulatory T-cell depletion releases adaptive immunity preventing carcinogenesis and suppressing established tumor growth. Cancer Res. 70:7800–7809. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Neophytou CM, Panagi M, Stylianopoulos T and Papageorgis P: The role of tumor microenvironment in cancer metastasis: Molecular mechanisms and therapeutic opportunities. Cancers (Basel). 13:20532021. View Article : Google Scholar : PubMed/NCBI | |
|
Baxevanis CN, Perez SA and Papamichail M: Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy. Cancer Immunol Immunother. 58:317–324. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Bhatia A and Kumar Y: Cellular and molecular mechanisms in cancer immune escape: A comprehensive review. Expert Rev Clin Immunol. 10:41–62. 2014. View Article : Google Scholar | |
|
Sasidharan Nair V and Elkord E: Immune checkpoint inhibitors in cancer therapy: A focus on T-regulatory cells. Immunol Cell Biol. 96:21–33. 2018. View Article : Google Scholar | |
|
Ruffell B, Denardo DG, Affara NI and Coussens LM: Lymphocytes in cancer development: Polarization towards pro-tumor immunity. Cytokine Growth Factor Rev. 21:3–10. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Rotte A, D'Orazi G and Bhandaru M: Nobel committee honors tumor immunologists. J Exp Clin Cancer Res. 37:2622018. View Article : Google Scholar : PubMed/NCBI | |
|
Dolan DE and Gupta S: PD-1 pathway inhibitors: Changing the landscape of cancer immunotherapy. Cancer Control. 21:231–237. 2014. View Article : Google Scholar | |
|
Sharma P, Wagner K, Wolchok JD and Allison JP: Novel cancer immunotherapy agents with survival benefit: Recent successes and next steps. Nat Rev Cancer. 11:805–812. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Sharma A, Suleyman N, Jones O and Vasdev N: Immunotherapy in urological tumors. Rev Urol. 21:15–20. 2019. | |
|
Steven A, Fisher SA and Robinson BW: Immunotherapy for lung cancer. Respirology. 21:821–833. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Dobosz P and Dzieciątkowski T: The intriguing history of cancer immunotherapy. Front Immunol. 10:29652019. View Article : Google Scholar | |
|
Fritz JM and Lenardo MJ: Development of immune checkpoint therapy for cancer. J Exp Med. 216:1244–1254. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Pennock GK and Chow LQ: The evolving role of immune checkpoint inhibitors in cancer treatment. Oncologist. 20:812–822. 2015. View Article : Google Scholar | |
|
Ahern E, Solomon BJ, Hui R, Pavlakis N, O'Byrne K and Hughes BGM: Neoadjuvant immunotherapy for non-small cell lung cancer: Right drugs, right patient, right time? J Immunother Cancer. 9:e0022482021. View Article : Google Scholar : PubMed/NCBI | |
|
Stege H, Haist M, Nikfarjam U, Schultheis M, Heinz J, Pemler S, Loquai C and Grabbe S: The status of adjuvant and neoadjuvant melanoma therapy, new developments and upcoming challenges. Target Oncol. 16:537–552. 2021. View Article : Google Scholar | |
|
Signorelli D, Giannatempo P, Grazia G, Aiello MM, Bertolini F, Mirabile A, Buti S, Vasile E, Scotti V, Pisapia P, et al: Patients selection for immunotherapy in solid tumors: Overcome the Naïve vision of a single biomarker. Biomed Res Int. 2019:90564172019. View Article : Google Scholar | |
|
Zhu J, Powis de Tenbossche CG, Cané S, Colau D, van Baren N, Lurquin C, Schmitt-Verhulst AM, Liljeström P, Uyttenhove C and Van den Eynde BJ: Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes. Nat Commun. 8:14042017. View Article : Google Scholar : PubMed/NCBI | |
|
Horton BL, Williams JB, Cabanov A, Spranger S and Gajewski TF: Intratumoral CD8+ T-cell apoptosis is a major component of T-cell dysfunction and impedes antitumor immunity. Cancer Immunol Res. 6:14–24. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Chaoul N, Tang A, Desrues B, Oberkampf M, Fayolle C, Ladant D, Sainz-Perez A and Leclerc C: Lack of MHC class II molecules favors CD8+ T-cell infiltration into tumors associated with an increased control of tumor growth. Oncoimmunology. 7:e14042132017. View Article : Google Scholar : PubMed/NCBI | |
|
Brunner-Weinzierl MC and Rudd CE: CTLA-4 and PD-1 control of T-cell motility and migration: Implications for tumor immunotherapy. Front Immunol. 9:27372018. View Article : Google Scholar | |
|
Balkhi MY: Receptor signaling, transcriptional, and metabolic regulation of T cell exhaustion. Oncoimmunology. 9:17473492020. View Article : Google Scholar : PubMed/NCBI | |
|
Salmon H, Idoyaga J, Rahman A, Leboeuf M, Remark R, Jordan S, Casanova-Acebes M, Khudoynazarova M, Agudo J, Tung N, et al: Expansion and activation of CD103(+) dendritic cell progenitors at the tumor site enhances tumor responses to therapeutic PD-L1 and BRAF inhibition. Immunity. 44:924–938. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Li KP, Shanmuganad S, Carroll K, Katz JD, Jordan MB and Hildeman DA: Dying to protect: Cell death and the control of T-cell homeostasis. Immunol Rev. 277:21–43. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Paludan SR, Pradeu T, Masters SL and Mogensen TH: Constitutive immune mechanisms: Mediators of host defence and immune regulation. Nat Rev Immunol. 21:137–150. 2021. View Article : Google Scholar | |
|
Fusi A and Dalgleish A: The importance for immunoregulation for long-term cancer control. Future Oncol. 13:1619–1632. 2017. View Article : Google Scholar | |
|
Lisovska N and Shanazarov N: Tumor progression mechanisms: Insights from the central immune regulation of tissue homeostasis. Oncol Lett. 17:5311–5318. 2019. | |
|
Bruni D, Angell HK and Galon J: The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy. Nat Rev Cancer. 20:662–680. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Lecis D, Sangaletti S, Colombo MP and Chiodoni C: Immune checkpoint ligand reverse signaling: Looking back to go forward in cancer therapy. Cancers (Basel). 11:6242019. View Article : Google Scholar | |
|
Rei M, Pennington DJ and Silva-Santos B: The emerging protumor role of γδ T lymphocytes: Implications for cancer immunotherapy. Cancer Res. 75:798–802. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Savage PA, Leventhal DS and Malchow S: Shaping the repertoire of tumor-infiltrating effector and regulatory T cells. Immunol Rev. 259:245–258. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Gourzones C, Barjon C and Busson P: Host-tumor interactions in nasopharyngeal carcinomas. Semin Cancer Biol. 22:127–136. 2012. View Article : Google Scholar | |
|
Fidler IJ: Lymphocytes are not only immunocytes. Biomedicine. 32:1–3. 1980.PubMed/NCBI | |
|
Thomas VA and Balthasar JP: Understanding inter-individual variability in monoclonal antibody disposition. Antibodies (Basel). 8:562019. View Article : Google Scholar | |
|
Wolf D, Sopper S, Pircher A, Gastl G and Wolf AM: Treg(s) in cancer: Friends or foe? J Cell Physiol. 230:2598–2605. 2015. View Article : Google Scholar | |
|
Sanmamed MF and Chen L: A paradigm shift in cancer immunotherapy: From enhancement to normalization. Cell. 175:313–326. 2018. View Article : Google Scholar | |
|
Bedognetti D, Ceccarelli M, Galluzzi L, Lu R, Palucka K, Samayoa J, Spranger S, Warren S, Wong KK, Ziv E, et al: Toward a comprehensive view of cancer immune responsiveness: A synopsis from the SITC workshop. J Immunother Cancer. 7:1312019. View Article : Google Scholar : PubMed/NCBI |
